Performance status of patients is the major prognostic factor at all stages of pancreatic cancer

Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s

Charles J. Yeo, John L. Cameron, Taylor A. Sohn et al. · Annals of Surgery · 1997 · 1.8K citations · Full text

Medicine, Pathology, Surgery +15

Hepatogastroenterology

Yidong Cai, Haoxuan Zheng, Wei Gong et al. · Hepatogastroenterology · 2011 · 1.3K citations

Medicine, Molecular Biology, Oncology +17

Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

Christophe Louvet, Roberto Labianca, Pascal Hammel et al. · Journal of Clinical Oncology · 2005 · 954 citations · Full text

Medicine, Oncology, Pharmacology +12

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.

Stephen Sener, Amy M. Fremgen, Herman R. Menck et al. · Journal of the American College of Surgeons · 1999 · 793 citations

Medicine, Oncology, Surgery +11

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Eric Van Cutsem, Helgi van de Velde, Petr Karásek et al. · Journal of Clinical Oncology · 2004 · 774 citations · Full text

Medicine, Oncology, Pharmacology +12